Tempus AI
the Lens agentic AI platform runs analyses over more than 8.5 million de-identified patient records and is used by 19 of the top 20 biopharma companies.
- Country
- United States
- Ticker
- NASDAQ: TEM
21 CFR Part 11
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | — | ✓ |
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioinformatics & multi-omics | bioinformatics-omics | Low | → |
| Multi-omics diagnostic panels for precision oncology | diagnostics-medtech | Medium | → |
| Personalized diagnostics | diagnostics-medtech | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.